Strides Pharma Science Limited - Balance (Quarterly)

Strides Pharma Science Limited
IN ˙ BSE ˙ INE939A01011
1.053,25 ₹ ↑0,70 (0,07%)
2026-04-29
DEL PRIS
Balance (Quarterly)

Strides Pharma Science Limited Balance viser kontosaldi for virksomheden på tidspunkter. Balancedata inkluderer aktiver, omsætningsaktiver, anlægsaktiver, materielle anlægsaktiver (PPE), inventar, immaterielle aktiver, passiver, kortfristede forpligtelser, gæld, kapitalleasingforpligtelser, almindelige aktier, overført overskud, egne aktier og egenkapital.

Alle tal er gange 1,000,000.00 undtagen pr. andel enheder.

2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
2025
09-30
Kontanter 3.927 1.707 1.269 3.035 2.632 1.610 1.755 1.126 1.428
Ændring (%) -56,53 -25,70 139,26 -13,28 -38,82 9,00 -35,86 26,90
Aktiver Nuværende 29.134 33.618 32.543 32.434 33.892 29.690 30.940 30.989 33.132
Ændring (%) 15,39 -3,20 -0,34 4,50 -12,40 4,21 0,16 6,91
Aktiver 68.435 69.759 68.449 66.384 63.378 58.398 59.896 60.487 65.206
Ændring (%) 1,93 -1,88 -3,02 -4,53 -7,86 2,57 0,99 7,80
Forpligtelser 44.098 45.925 45.431 44.655 43.443 37.680 37.746 34.623 37.178
Ændring (%) 4,14 -1,08 -1,71 -2,72 -13,26 0,17 -8,28 7,38
Egenkapital 24.337 23.833 23.018 21.729 19.935 20.717 22.150 25.865 28.028
Ændring (%) -2,07 -3,42 -5,60 -8,25 3,92 6,92 16,77 8,36
Passiver og Aktiekapital 68.435 69.759 68.449 66.384 63.378 58.398 59.896 60.487 65.206
Ændring (%) 1,93 -1,88 -3,02 -4,53 -7,86 2,57 0,99 7,80

Source: Capital IQ

Other Listings
IN:STAR 1.052,55 ₹
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista